Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Priti Pednekar
Observed name:
P Pednekar
Institution:
Astellas Pharma (United States)
Observed institution:
Astellas Pharma (United States)
OpenAlex ID:
A5034195229
Treatment patterns among Medicare beneficiaries with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2020-2024.
2026
·
Ronald C. Chen
, Kimberly Donnowitz
, et al.
·
JCO Oncology Practice
PDF
Treatment patterns among US patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2021–2024: Retrospective cohort study using the IQVIA database.
2026
·
Ronald C. Chen
, Kimberly Donnowitz
, et al.
·
JCO Oncology Practice
PDF
Ee161 Healthcare Resource Utilization and Costs Associated With Transfusion Burden in Older Us Patients With Relapsed Flt3-mutated Acute Myeloid Leukemia Who Were Prescribed Gilteritinib: a Medicare Claims-based Cohort Study
2026
·
Priti Pednekar
, Alana Block
, et al.
·
Value in Health
PCR15 Criteria for the Value Assessment for Medication Adherence-Enhancing Interventions
2024
·
D Nayak
, B Borah
, et al.
·
Value in Health
HTA193 Criteria for Value Assessment of Medication Adherence-Enhancing Interventions: Preliminary Results of a Systematic Review
2022
·
T Agh
, M Hiligsmann
, et al.
·
Value in Health
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type